Nettoinventarwert (NAV)
| 124.00 USD | USD | % |
|---|
| Vortag | USD | Datum | 30.09.2026 |
Massada ETP (Series 462) Notes due 2041 USD Accumulation Kurs - 1 Jahr
Top Kryptowährungen ETPs
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Raydium ETP | CH1480821391 | 187.96% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 155.99% | |
| 21shares Ethena ETP | CH1506167035 | 133.37% | |
| 21Shares Stacks ETP | CH1258969042 | 117.24% | |
| 21Shares Arbitrum ETP | CH1304867463 | 108.68% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 232.76% | |
| 21Shares Raydium ETP | CH1480821391 | 140.90% | |
| 21Shares Injective Staking ETP | CH1360612134 | 124.79% | |
| 21Shares Uniswap ETP | CH1135202096 | 116.32% | |
| 21shares Ethena ETP | CH1506167035 | 94.33% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 90.46% | |
| 21shares Hyperliquid Staking ETP | CH1471826029 | 67.24% | |
| 21Shares Uniswap ETP | CH1135202096 | 5.99% | |
| 21Shares Raydium ETP | CH1480821391 | -6.12% | |
| 21Shares Injective Staking ETP | CH1360612134 | -7.38% |
Fundamentaldaten
| Valor | |
| ISIN | XS2415308258 |
| Emittent | Bancaribe Capital LLC |
| Aufgelegt in | Ireland |
| Auflagedatum | 30.11.2021 |
| Kategorie | Mischfonds Sonstige |
| Währung | USD |
| Volumen | |
| Depotbank | |
| Geschäftsjahresende | |
| Berichtsstand | 06.10.2026 |
Anlagepolitik
So investiert der Massada ETP (Series 462) Notes due 2041 USD Accumulation: The Portfolio Manager, in accordance with the terms of the Portfolio Management Agreement, shall be obliged to use all reasonable endeavours, in the course of carrying out such obligations, to pursue an investment strategy that maximises the total returns achieved by the Portfolio by long term growth and preservation of capital to be achieved by the reinvestment of bond coupon payments and proper geographical duration and issuer diversification. The Portfolio asset allocation should be as follows: 30-100% in bonds, 0-50% in equity and equity linked structured products, 0- 20% in cash, and 0-10% in alternatives. There should not be short-term liquidity needs and the target return should be between 5-7%.